Micronuclei, which are small nucleus-like structures within cells, are commonly associated with tumors. Now, researchers from Tsukuba, Japan have developed an automated computer program that can accurately and reproducibly ...
Sep 17, 2021
0
116
Image-guided radiation therapy has evolved to include the ability to track tumors in real time during treatment. It's improving cure rates and limiting side effects for a growing number of cancer patients.
Sep 16, 2021
0
2
Results from a study published in Psycho-Oncology suggest that women with breast cancer recover from negative impacts of mastectomy on body image within four years of surgery, whether they have immediate, delayed, or no breast ...
Sep 9, 2021
0
44
Researchers at the Francis Crick Institute have identified visual changes in the bone marrow caused by acute myeloid leukemia (AML). The imaging technique used is now being tested in hospital to see if it could help predict ...
Aug 3, 2021
0
125
With the help of a topical fluorescent imaging agent, cervical cancer can be identified by physicians with a hand-held microscope, according to research published in the July issue of The Journal of Nuclear Medicine. Targeting ...
Jul 27, 2021
0
405
(HealthDay)—Many of the alterations made to clinical trial procedures during the COVID-19 pandemic should be implemented in the post-COVID-19 roadmap, according to an article published online July 21 in Cancer Discovery.
Jul 22, 2021
0
1
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men.
Jul 7, 2021
0
9
Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types, and has recently been shown to provide a modest survival benefit for patients with recurrent glioblastoma. To improve ...
Jun 29, 2021
0
13
Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis. These tests are often performed on tissue biopsy samples that require invasive procedures ...
Jun 17, 2021
0
2
A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL in detecting and localizing recurrent prostate cancer. Approved by the U.S. Food ...
Jun 15, 2021
0
3
